Inhibitors of Synaptogenesis and Mental Health
突触发生和心理健康的抑制剂
基本信息
- 批准号:10468640
- 负责人:
- 金额:$ 49.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:1q32AblationAcousticsAdultAffectAllelesAnatomyAnxietyAttention deficit hyperactivity disorderBehaviorBehavioralBindingBinding ProteinsBiochemical PathwayBiochemistryBiological AssayBiologyBiotinBipolar DisorderBrainBrain regionChromatinChromosomesCo-ImmunoprecipitationsComplementComplexDefectDevelopmentDiseaseElectrophysiology (science)EmbryoEnsureEpisodic memoryExcitatory SynapseExhibitsFamilyFamily memberGTPase-Activating ProteinsGene DosageGene ExpressionGene FamilyGenesGeneticGenetic RiskGenetic studyGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHippocampus (Brain)HistologicHumanImpairmentKnock-outKnockout MiceKnowledgeLabelLeadLinkMagnetic Resonance ImagingMapsMental HealthMental disordersMethodsMonitorMood DisordersMorphologyMusMutant Strains MiceMutationNeuronsNeurophysiology - biologic functionNeurotic DisordersPathway interactionsPhenotypePhysiologyPlayPoint MutationPredispositionProcessProsencephalonProtein DeficiencyProteinsProteomicsReportingResearchResolutionRiskRisk FactorsRoleSchizophreniaSemaphorinsSignal TransductionStartle ReactionStructureSynapsesSynaptic TransmissionSystemTechniquesTertiary Protein StructureTestingTransgenic MiceVariantVertebral columnautism spectrum disorderaxon guidanceaxonal pathfindingbasebehavioral impairmentbehavioral phenotypingbiochemical toolsbrain morphologycell motilitycell typeconditional knockoutdensitydentate gyrusexperimental studyfetalgene functiongenetic approachgenetic variantgranule cellinhibitorinsightinterdisciplinary approachinterestmembermigrationmouse geneticsmutantneural circuitneurodevelopmentneuroepitheliumneuropsychiatric disorderneuropsychiatryneuroregulationneurotransmissionnovelnovel therapeutic interventionplexinprotein functionreceptorrelating to nervous systemsexstem cellssymptomatologysynaptic functionsynaptogenesistrait
项目摘要
Mounting evidence suggests that many neuropsychiatric disorders have a developmental origin with a strong
genetic underpinning. A large number of allelic variants has been identified that associate with mental illness.
While genetic discoveries are a crucial first step, the next major challenge is to define the biochemical
pathways altered by disease alleles and to develop a more nuanced understanding of how these dysfunctional
pathways disrupt brain function relevant to disease symptomatology. Of interest, mutations in members of the
SEMAPHORIN (SEMA) family of axon guidance molecules, and their receptors, the PLEXINS (PLXN) carry
varying genetic risks for mental illness. Allelic variants of SEMA5A and its receptor PLXNA2 associated with
mood disorders cause reduced gene expression. To explore the underlying biology of how reduced
SEMA5A/PLXNA2 expression may contribute to mental illness, we use Plxna2 transgenic mice as an
experimental system. Morphological studies with Sema5a and Plxna2 mutant mice identified distinct
anatomical phenotypes: defects in migration of early-born dentate granule cells (GCs) progenitors from the
primary neuroepithelium to the dentate gyrus (DG) and an increase in spine synapse density in mature GCs in
the DG. Adult Plxna2 mice exhibit gene-dosage and sex-specific behavioral defects in episodic memory,
sensorimotor gating, and sociability; traits commonly observed in psychiatric disorders including
Schizophrenia. For a deeper understanding of how Plxna2 deficiency may contribute to behavioral phenotypes,
we used gene editing to disrupt the GTPase-activating protein (GAP) domain in the PlxnA2 cytoplasmic region.
Loss of PlxnA2-GAP enzymatic activity impairs Rap1-GTPase dependent GC progenitor migration and leads to
supernumerary spine synapses in mature GC. Moreover, PlxnA2-GAP deficiency disrupts episodic memory
and sensorimotor gating. To probe deeper into how impaired Sema5A/PlxnA2-GAP/Rap1 signaling leads to
behavioral defects, we used a proteomics-based approach and identified novel PlxnA2 interacting proteins. In
the current application we propose a multidisciplinary approach comprised of recently developed biochemical
tools, electrophysiological techniques, conditional gene ablation and mouse behavior. SPECIFIC AIM 1 is
aimed at the characterization of novel mechanisms that regulate Sema5A-PlxnA2 signaling, including the
guanine nucleotide exchange factors (GEFs) that antagonize PlxnA2-GAP activity. SPECIFIC AIM 2 builds on
our observation that forebrain specific ablation of Plxna2 mimics behavioral defects observed in Plxna2
germline null mice. We pursue a mouse genetic approach to identify developmental epochs of vulnerability
and the neural substrate associated with impaired behaviors in Plxna2-/- and Plxna2-GAP deficient mice.
Genetic studies will be complemented by electrophysiological recordings, histological analyses and high-
resolution magnetic resonance imaging. Studies are aimed at determining where and when Plxna2-GAP
function is required during brain development to ensure normal behavior in adulthood.
越来越多的证据表明,许多神经精神疾病的发育起源很强
遗传基础。已经确定了许多与精神疾病相关的等位基因变体。
遗传发现是至关重要的第一步,但下一个主要挑战是定义生化
疾病等位基因改变的途径,并对这些功能失调的方式产生更细微的理解
途径破坏与疾病症状相关的大脑功能。感兴趣的是,成员的突变
轴突引导分子的信号素(SEMA)家族及其受体,丛蛋白(PLXN)携带
精神疾病的遗传风险有所不同。 Sema5a的等位基因变体及其受体PLXNA2与
情绪障碍会导致基因表达降低。探讨如何减少的生物学
SEMA5A/PLXNA2表达可能导致精神疾病,我们使用PLXNA2转基因小鼠作为一种
实验系统。 SEMA5A和PLXNA2突变小鼠的形态学研究确定了不同的
解剖表型:早期出生的牙齿颗粒细胞(GCS)祖细胞的迁移缺陷
对齿状回(DG)的一级神经上皮和成熟GC中脊柱突触密度的增加
DG。成年PLXNA2小鼠在情节记忆中表现出基因剂量和性别特异性行为缺陷,
感觉运动门控和社交能力;通常在精神疾病中观察到的特征
精神分裂症。为了更深入地了解PLXNA2缺乏症如何促进行为表型,
我们使用基因编辑来破坏PLXNA2细胞质区域中GTPase激活蛋白(GAP)结构域。
plxNA2-a-pAP酶活性的丧失会损害RAP1-GTPase依赖GC祖细胞迁移,并导致
成熟的GC中的超努脊柱突触。此外,plxna2-gap缺乏破坏了情节记忆
和感觉运动门控。更深入地探讨SEMA5A/PLXNA2-GAP/RAP1信号的受损如何导致
行为缺陷,我们使用了一种基于蛋白质组学的方法,并鉴定了新型的PLXNA2相互作用蛋白。在
我们提出的当前应用程序由最近开发的生化方法组成
工具,电生理技术,有条件的基因消融和小鼠行为。具体目标1是
针对调节SEMA5A-PLXNA2信号的新机制的表征,包括
与PLXNA2-GAP活性拮抗的鸟嘌呤核苷酸交换因子(GEFS)。特定的目标2建立
我们的观察到,PLXNA2的前脑特异性消融模仿PLXNA2中观察到的行为缺陷
种系无鼠。我们采用鼠标遗传方法来识别脆弱性的发展时期
以及与PLXNA2 - / - 和PLXNA2-GAP缺陷小鼠中行为受损相关的神经底物。
遗传学研究将由电生理记录,组织学分析和高度互补
分辨率磁共振成像。研究旨在确定何时何地plxna2-gap
在大脑发育过程中需要功能以确保成年后正常行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roman Jeno Giger其他文献
Roman Jeno Giger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roman Jeno Giger', 18)}}的其他基金
Development of live-cell probes to investigate tubulin post-translational modifications in neuronal regeneration
开发活细胞探针来研究神经元再生中微管蛋白翻译后修饰
- 批准号:
10648255 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别:
Inhibitors of Synaptogenesis and Mental Health
突触发生和心理健康的抑制剂
- 批准号:
10224879 - 财政年份:2019
- 资助金额:
$ 49.61万 - 项目类别:
Inhibitors of Synaptogenesis and Mental Health
突触发生和心理健康的抑制剂
- 批准号:
10682405 - 财政年份:2019
- 资助金额:
$ 49.61万 - 项目类别:
Inhibitors of Synaptogenesis and Mental Health
突触发生和心理健康的抑制剂
- 批准号:
10023276 - 财政年份:2019
- 资助金额:
$ 49.61万 - 项目类别:
Nogo Receptor Family: Novel Mechanisms to Inhibit Growth
Nogo 受体家族:抑制生长的新机制
- 批准号:
6822187 - 财政年份:2004
- 资助金额:
$ 49.61万 - 项目类别:
Nogo Receptor Family: Novel Mechanisms to Inhibit Growth
Nogo 受体家族:抑制生长的新机制
- 批准号:
7116772 - 财政年份:2004
- 资助金额:
$ 49.61万 - 项目类别:
相似国自然基金
典型草原不同退化类型雪水消融过程水分转换效率研究
- 批准号:32360295
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于超声混合深度神经网络对PIMSRA心肌热消融边界的实时可视化与识别研究
- 批准号:82302204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于荷顺铂温敏纳米凝胶载KU135介入栓塞联合射频消融治疗肝癌的实验研究
- 批准号:82302331
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
消融热效应下肝癌超级增强子驱动的DNAJB1与cIAP2互作对中性粒细胞胞外诱捕网(NETs)形成的作用及机制探究
- 批准号:82302319
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别:
Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue Sarcoma
超声引导超可控组织解剖阵列系统用于软组织肉瘤的无创治疗
- 批准号:
10649994 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别:
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
高强度超声消融室间隔缩小术治疗肥厚型心肌病
- 批准号:
10818081 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别:
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
- 批准号:
10603460 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别:
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
- 批准号:
10851470 - 财政年份:2023
- 资助金额:
$ 49.61万 - 项目类别: